Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus

Rheumatology (United Kingdom)

Volumn 50, Issue 6, 2011, Pages 1064-1069

  Ekman, Carl ^a   Jönsen, Andreas ^a   Sturfelt, Gunnar ^a   Bengtsson, Anders A ^a   Dahlbäck, Björn ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Axl; Growth arrest specific protein 6; Inflammation; Receptor tyrosine kinase; Systemic lupus erythematosus; Vitamin K

Indexed keywords

C REACTIVE PROTEIN; DNA ANTIBODY; GROWTH ARREST SPECIFIC PROTEIN 6; HEMOGLOBIN; PROTEIN DERIVATIVE; PROTEIN SAXL; UNCLASSIFIED DRUG; AXL RECEPTOR TYROSINE KINASE; BIOLOGICAL MARKER; GROWTH ARREST-SPECIFIC PROTEIN 6; ONCOPROTEIN; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 85012054549     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq459     Document Type: Article

References (27)

1. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 1995;38:551-8.
2. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A. Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology 2007;46:1052-6.
3. Munoz LE, Gaipl US, Franz S et al. SLE-a disease of clearance deficiency? Rheumatology 2005;44:1101-7.
4. Ronnblom L, Alm GV, Eloranta ML. Type I interferon and lupus. Curr Opin Rheumatol 2009;21:471-7.
5. Baechler EC, Batliwalla FM, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 2003;100:2610-5.
6. Alciato F, Sainaghi PP, Sola D, Castello L, Avanzi GC. TNF-alpha, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages. J Leukoc Biol 2010;87: 869-75.
7. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007;131:1124-36.
8. Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (Gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993;13:4976-85.
9. Angelillo-Scherrer A, de Frutos P, Aparicio C et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001;7:215-21.
10. Balogh I, Hafizi S, StenhoffJ, Hansson K, Dahlback B. Analysis of Gas6 in human platelets and plasma. Arterioscler, Thromb, Vasc Biol 2005;25:1280-6.
11. Borgel D, Clauser S, Bornstain C et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006;34:219-22.
12. Gibot S, Massin F, Cravoisy A et al. Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit Care 2007;11:R8.
13. Uehara S, Handa H, Gotoh K, Tomita H, Sennshuu M. Plasma concentrations of growth arrest-specific protein 6 and protein S in patients with acute pancreatitis. J Gastroenterol Hepatol 2009;24:1567-73.
14. Stitt TN, Conn G, Gore M et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 1995;80: 661-70.
15. Goruppi S, Ruaro E, Varnum B, Schneider C. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol 1997;17:4442-53.
16. StenhoffJ, Dahlback B, Hafizi S. Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. Biochem Biophys Res Commun 2004; 319:871-8.
17. O'Bryan JP, Frye RA, Cogswell PC et al. Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991;11:5016-31.
18. Vajkoczy P, Knyazev P, Kunkel A et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci USA 2006;103: 5799-804.
19. Gustafsson A, Martuszewska D, Johansson M et al. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Clin Cancer Res 2009;15:4742-9.
20. Ekman C, Site DF, Gottsater A, Lindblad B, Dahlback B. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms. Clin Biochem 2010;43:110-4.
21. Park IK, Giovenzana C, Hughes TL, Yu J, Trotta R, Caligiuri MA. The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development. Blood 2009;113:2470-7.
22. Yanagita M, Arai H, Ishii K et al. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol 2001;158: 1423-32.
23. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
24. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288-91.
25. Suh CH, Hilliard B, Li S, Merrill JT, Cohen PL. TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther 2010;12:R146.
26. Nagai K, Arai H, Yanagita M et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 2003;278: 18229-34.
27. Yanagita M, Ishimoto Y, Arai H et al. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J Clin Invest 2002;110:239-46.